STVNStevanato Group S.p.A.
Is it growing?
Neither accelerating nor breaking down: earnings up +19% year on year, but operating margin narrowing (−2.5 points).
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +12% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.
Trailing-twelve-month operating margin, 16.8% now against 19.2% a year earlier.
All from SEC EDGAR, as of Dec 31, 2025.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is STVN growing?
Stevanato Group S.p.A. has grown revenue 6.4% a year over three years and 12% a year over five, with earnings per share compounding at −1.9%.
Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · steady growth, ahead of inflation · compounded from fiscal years as filed
- Revenue growth, 5-year rate
- +12%
Revenue growth, 5-year rate · +6.4% over three · growth has slowed since the five-year average
- Earnings per share, 3-year rate
- −1.9%
Earnings per share, 3-year rate · revenue +6.4% · earnings lagged revenue: the growth is costing something
- Years of annual history on file
- 7
Years of annual history on file · FY2019 to FY2025, as filed
Details›
- Revenue FY2021
- $844M
- Revenue FY2022
- $984M
- Revenue FY2023
- $1.09B
- Revenue FY2024
- $1.10B
- Revenue FY2025
- $1.19B
Annual income statements as filed with the SEC.
Medical Instruments & Supplies
Ranks #4 of 21 by RyuScore